Chemcon Speciality Chemicals Limited — PPTs, 07-08-2025: Investor Presentation

Here's a summary of the attached investor presentation:

**1. Financial Highlights:**

For Q1 FY26, revenue stood at ₹53.5 Cr, an 18% increase year-over-year. Profit After Tax (PAT) rose 19% YoY to ₹6.4 Cr, achieving a healthy 11.9% PAT margin. EBITDA was ₹7.7 Cr, up 8% YoY. Organic Chemicals represented 79% of the business, with exports contributing 70% of Q1 FY26 revenue. The balance sheet as of March 2025 shows stable total assets at ₹553.9 Cr and robust equity at ₹500.7 Cr, alongside a reduction in current liabilities.

**2. Strategic Initiatives & Growth Drivers:**

Construction of the new P-10 and P-11 plants, focused on manufacturing organic chemicals, is on track for Q3 FY26 operationalization. The company prioritizes capacity expansion, exploring new product applications for diversification, import substitution within India’s organic chemicals market, and enhancing cost efficiencies through process re-engineering.

**3. Business Developments:**

The Organic Chemicals segment (including HMDS, CMIC, and Bromobenzene) experienced a steady demand recovery, though pricing was moderated due to supply from China. Demand for Inorganic Chemicals (Bromides) was impacted by global oil drilling volatility, with recovery anticipated in coming quarters.

**4. Market Position & Competitive Advantage:**

The company holds unique positions as India's sole manufacturer of HMDS and Zinc Bromide, and the world's largest producer of CMIC. It boasts over two decades of chemical manufacturing expertise, long-standing customer relationships, and strong in-house R&D capabilities, operating as a zero-discharge company.

**5. Investor Implications:**

The strong Q1 FY26 performance points to positive growth potential, particularly in the Organic Chemicals sector. Future capacity additions and new product initiatives are key growth catalysts. Investors should monitor global demand volatility and pricing pressures as execution factors.